African swine fever virus(ASFV)poses a significant threat to the global swine industry.Currently,there are no effective vaccines or treatments available to combat ASFV infection in pigs.The primary means of controllin...African swine fever virus(ASFV)poses a significant threat to the global swine industry.Currently,there are no effective vaccines or treatments available to combat ASFV infection in pigs.The primary means of controlling the spread of the disease is through rapid detection and subsequent elimination of infected pig.Recently,a lower virulent ASFV isolate with a deleted EP402R gene(CD2v-deleted)has been reported in China,which further complicates the control of ASFV infection in pig farms.Furthermore,an EP402R-deleted ASFV variant has been developed as a potential live attenuated vaccine candidate strain.Therefore,it is crucial to develop detection methods that can distinguish wild-type and EP402R-deleted ASFV infections.In this study,two recombinant ASFV-p72 and-CD2v proteins were expressed using a prokaryotic system and used to immunize Bactrian camels.Subsequently,eight nanobodies against ASFV-p72 and ten nanobodies against ASFV-CD2v were screened.Following the production of these nanobodies with horse radish peroxidase(HRP)fusion proteins,the ASFV-p72-Nb2-HRP and ASFV-CD2v-Nb22-HRP fusions were selected for the development of two competitive ELISAs(cELISAs)to detect anti-ASFV antibodies.The two cELISAs exhibited high sensitivity,good specificity,repeatability,and stability.The coincidence rate between the two cELISAs and commercial ELISA kits was 98.6%and 97.6%,respectively.Collectively,the two cELISA for detecting antibodies against ASFV demonstrated ease of operation,a low cost,and a simple production process.The two cELISAs could determine whether pigs were infected with wild-type or CD2v-deleted ASFV,and could play an important role in monitoring ASFV infections in pig farms.展开更多
African swine fever virus(ASFV) infection is a big threat to the global pig industry. Because there is no effective vaccine, rapid, low-cost, and simple diagnosis methods are necessary to detect the ASFV infection in ...African swine fever virus(ASFV) infection is a big threat to the global pig industry. Because there is no effective vaccine, rapid, low-cost, and simple diagnosis methods are necessary to detect the ASFV infection in pig herds.Nanobodies, with advantages of small molecular weight and easy genetic engineering, have been universally used as reagents for developing diagnostic kits. In this study, the recombinant ASFV-p30 was expressed and served as an antigen to immunize the Bactrian camel. Then, seven nanobodies against ASFV-p30 were screened using phage display technique. Subsequently, the seven nanobodies fused horseradish peroxidase(nanobody-HRP) were secretory expressed and one fusion protein ASFV-p30-Nb75-HRP was selected with the highest sensitivity in blocking ELISA. Using the ASFV-p30-Nb75-HRP fusion protein as a probe, a competitive ELISA(cELISA) was developed for detecting anti-ASFV antibodies in pig sera. The cut-off value of cELISA was determined to be 22.7%by testing 360 negative pig sera. The detection limit of the cELISA for positive pig sera was 1:320, and there was no cross-reaction with anti-other swine virus antibodies. The comparative assay showed that the agreement of the cELISA with a commercial ELISA kit was 100%. More importantly, the developed cELISA showed low cost and easy production as a commercial kit candidate. Collectively, a simple nanobody-based cELISA for detecting antibodies against ASFV is developed and it provides a new method for monitoring ASFV infection in the pig herds.展开更多
基金supported by the Natural Science Foundation of China(grant no.32273041)the Natural Science Foundation of Shaanxi Province of China(grant no.2022JC-12)+1 种基金the Key R&D Program of Shaanxi Province(grant no.S2022-YF-YBNY-0673)the Central Public-interest Scientific Institution Basal Research Fund.
文摘African swine fever virus(ASFV)poses a significant threat to the global swine industry.Currently,there are no effective vaccines or treatments available to combat ASFV infection in pigs.The primary means of controlling the spread of the disease is through rapid detection and subsequent elimination of infected pig.Recently,a lower virulent ASFV isolate with a deleted EP402R gene(CD2v-deleted)has been reported in China,which further complicates the control of ASFV infection in pig farms.Furthermore,an EP402R-deleted ASFV variant has been developed as a potential live attenuated vaccine candidate strain.Therefore,it is crucial to develop detection methods that can distinguish wild-type and EP402R-deleted ASFV infections.In this study,two recombinant ASFV-p72 and-CD2v proteins were expressed using a prokaryotic system and used to immunize Bactrian camels.Subsequently,eight nanobodies against ASFV-p72 and ten nanobodies against ASFV-CD2v were screened.Following the production of these nanobodies with horse radish peroxidase(HRP)fusion proteins,the ASFV-p72-Nb2-HRP and ASFV-CD2v-Nb22-HRP fusions were selected for the development of two competitive ELISAs(cELISAs)to detect anti-ASFV antibodies.The two cELISAs exhibited high sensitivity,good specificity,repeatability,and stability.The coincidence rate between the two cELISAs and commercial ELISA kits was 98.6%and 97.6%,respectively.Collectively,the two cELISA for detecting antibodies against ASFV demonstrated ease of operation,a low cost,and a simple production process.The two cELISAs could determine whether pigs were infected with wild-type or CD2v-deleted ASFV,and could play an important role in monitoring ASFV infections in pig farms.
基金supported by the Natural Science Foundation of China (grant no. 31941016 and 31972676)the Natural Science Foundation of Shaanxi Province of China (grant no. 2022JC-12)the Key R&D Program of Shaanxi Province (grant no. S2022-YF-YBNY0673)
文摘African swine fever virus(ASFV) infection is a big threat to the global pig industry. Because there is no effective vaccine, rapid, low-cost, and simple diagnosis methods are necessary to detect the ASFV infection in pig herds.Nanobodies, with advantages of small molecular weight and easy genetic engineering, have been universally used as reagents for developing diagnostic kits. In this study, the recombinant ASFV-p30 was expressed and served as an antigen to immunize the Bactrian camel. Then, seven nanobodies against ASFV-p30 were screened using phage display technique. Subsequently, the seven nanobodies fused horseradish peroxidase(nanobody-HRP) were secretory expressed and one fusion protein ASFV-p30-Nb75-HRP was selected with the highest sensitivity in blocking ELISA. Using the ASFV-p30-Nb75-HRP fusion protein as a probe, a competitive ELISA(cELISA) was developed for detecting anti-ASFV antibodies in pig sera. The cut-off value of cELISA was determined to be 22.7%by testing 360 negative pig sera. The detection limit of the cELISA for positive pig sera was 1:320, and there was no cross-reaction with anti-other swine virus antibodies. The comparative assay showed that the agreement of the cELISA with a commercial ELISA kit was 100%. More importantly, the developed cELISA showed low cost and easy production as a commercial kit candidate. Collectively, a simple nanobody-based cELISA for detecting antibodies against ASFV is developed and it provides a new method for monitoring ASFV infection in the pig herds.
